SCHEMBL26638240

SCHEMBL26638240

CC(Oc1ccc(Cl)cc1)C(=O)NOC1CN(C(=O)O)C1

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 1/20 0.46
▸ KMT2A Q03164 3/20 0.45
▸ MEN1 O00255 2/20 0.45
▸ SMN1; SMN2 Q16637 1/20 0.45
▸ ADORA3 P0DMS8 1/20 0.44
▸ ADORA2A P29274 1/20 0.44
▸ ADORA1 P30542 1/20 0.44
▸ CRHBP P24387 1/20 0.43
▸ CRHR2 Q13324 1/20 0.43
▸ OGG1 O15527 1/20 0.41
▸ ALDH1A1 P00352 2/20 0.41
▸ POLB P06746 1/20 0.41
▸ CYP1A2 P05177 1/20 0.40
▸ CYP2C9 P11712 1/20 0.40
▸ CYP2C19 P33261 1/20 0.40
▸ EPHX2 P34913 1/20 0.40
▸ APOBEC3A P31941 1/20 0.39
▸ APOBEC3G Q9HC16 1/20 0.39
▸ GAA P10253 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26638239 1.00 LMNA (0.46) LMNAKMT2AMEN1SMN1; SMN2ADORA3
SCHEMBL26638111 0.91 LMNA (0.47) LMNAKMT2AMEN1SMN1; SMN2ADORA3
SCHEMBL26638112 0.91 LMNA (0.47) LMNAKMT2AMEN1SMN1; SMN2ADORA3
SCHEMBL26638191 0.85 LMNA (0.45) LMNAKMT2AMEN1SMN1; SMN2ADORA3
SCHEMBL26638193 0.85 LMNA (0.45) LMNAKMT2AMEN1SMN1; SMN2ADORA3
SCHEMBL22805428 0.85 LMNA (0.42) LMNAKMT2AMEN1SMN1; SMN2ADORA3
SCHEMBL22805429 0.85 LMNA (0.42) LMNAKMT2AMEN1SMN1; SMN2ADORA3
SCHEMBL26638048 0.84 LMNA (0.47) LMNAKMT2AMEN1SMN1; SMN2ADORA3
SCHEMBL26638054 0.84 LMNA (0.47) LMNAKMT2AMEN1SMN1; SMN2ADORA3
SCHEMBL22805210 0.83 LMNA (0.49) LMNAKMT2AMEN1SMN1; SMN2ADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3986873-B9 5-[(1S)-1-(4-BROMOPHENOXY)ETHYL]-2H-TETRAZOLE DERIVATIVES AND RELATED COMPOUNDS AS CLC-1 ION CHANNEL INHIBITORS FOR TREATING NEUROMUSCULAR DISORDERS NMD PHARMA AS (DK) 2024-05-29 — — EP claimed
EP-3986873-B1 5-[(1S)-1-(4-BROMOPHENOXY)ETHYL]-2H-TETRAZOLE DERIVATIVES AND RELATED COMPOUNDS AS CLC-1 ION CHANNEL INHIBITORS FOR TREATING NEUROMUSCULAR DISORDERS NMD PHARMA AS (DK) 2023-11-15 — — EP claimed
Send feedback